Repeatable Battery for the Assessment of Neuropsychological Status as a Screening Test in Schizophrenia, I: Sensitivity, Reliability, and Validity
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Cognitive impairment is an important feature of schizophrenia and is correlated with functional outcome. However, psychiatry lacks a screening instrument that can reliably assess the types of cognitive impairment often seen in schizophrenia. The authors assessed the sensitivity, convergent validity, and reliability of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) as well as the relationship of the RBANS to symptoms and employment status. This newly published test takes 25 minutes to administer and was standardized on a U.S.-Census-matched adult population. The test provides a total score and five index scores, each with a mean value of 100 (SD = 15). METHOD: RBANS data were obtained from 129 patients with schizophrenia in the outpatient and inpatient programs of the Maryland Psychiatric Research Center. RBANS data were correlated with WAIS-III and Wechsler Memory Scale, 3rd ed. performance in 38 patients. Reliability data for alternate forms of the RBANS were obtained from 53 patients; symptom ratings were obtained from 48 patients; and employment status was examined in 77 patients. RESULTS: The patients with schizophrenia demonstrated marked impairment on the RBANS (their mean total score was 71.4). The patients' index scores suggested that they had relatively less impairment of language and visual functions than of memory and attention. The RBANS demonstrated high correlations with full-scale IQ and memory measures. The total score demonstrated good reliability. RBANS performance minimally correlated with Brief Psychiatric Rating Scale ratings but was strongly related to employment outcome. CONCLUSIONS: The RBANS appears to be a useful cognitive screening instrument in schizophrenia. The instrument may be a useful prognostic indicator and offers a means of assessing cognitive status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
Saykin, A. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020048005 · Cited by 1,086
Braff, D. L. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340023003 · Cited by 399
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.799 · Cited by 397
Neuropsychological Assessment of Monozygotic Twins Discordant for Schizophrenia
Goldberg, T. E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230082013 · Cited by 384
Harvey, P. D., Howanitz, E., Parrella, M., White, L., Davidson, M., Mohs, R. C., Hoblyn, J., & Davis, K. L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.8.1080 · Cited by 338
Censits, D. M., Daniel Ragland, J., Gur, R. C., & Gur, R. E. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00091-6 · Cited by 285
Buchanan, R. W., Holstein, C., & Breier, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90082-5 · Cited by 281
Self-citation
Cited by
Keefe, R. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.011 · Cited by 1,573
Keefe, R. S. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.633 · Cited by 1,065
Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
Olincy, A., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 527
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
“The subjects also received the RBANS digit span test (forward subtest only) because this test had been sensitive to DMXB-A in the initial phase 1 trial (20).”
MethodSelf-citationFalleti, M. G., Maruff, P., Collie, A., & Darby, D. G. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390500205718 · Cited by 422
Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model
MCGURK, S. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.009 · Cited by 392
Davidson, M., Galderisi, S., Weiser, M., Werbeloff, N., Fleischhacker, W. W., Keefe, R. S., Boter, H., Keet, I. P. M., Prelipceanu, D., Rybakowski, J. K., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08060806 · Cited by 320
Cognitive functioning in patients with schizophrenia and bipolar disorder: A quantitative review
Krabbendam, L., Arts, B., van Os, J., & Aleman, A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.004 · Cited by 312
Voineskos, A. N., Rajji, T. K., Lobaugh, N. J., Miranda, D., Shenton, M. E., Kennedy, J. L., Pollock, B. G., & Mulsant, B. H. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.009 · Cited by 302
Lewis, D. A., Cho, R. Y., Carter, C. S., Eklund, K., Forster, S., Kelly, M. A., & Montrose, D. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030395 · Cited by 292
Cognitive Correlates of Job Tenure Among Patients With Severe Mental Illness
Gold, J. M., Goldberg, R. W., McNary, S. W., Dixon, L. B., & Lehman, A. F. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1395 · Cited by 288
Self-citationThe assessment of neuropsychological functioning in schizophrenia
Reichenberg, A. (. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/areichenberg · Cited by 271
Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression
Holtzheimer, P. E., McDonald, W. M., Mufti, M., Kelley, M. E., Quinn, S., Corso, G., & Epstein, C. M. (2010) · Depression and Anxiety · doi:10.1002/da.20731 · Cited by 204
Buchanan, R. W., Keefe, R. S. E., Lieberman, J. A., Barch, D. M., Csernansky, J. G., Goff, D. C., Gold, J. M., Green, M. F., Jarskog, L. F., Javitt, D. C., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.052 · Cited by 172
Self-citationGalantamine for the treatment of cognitive impairments in people with schizophrenia
Buchanan, R. W., Conley, R. R., Dickinson, D., Ball, M. P., Feldman, S., Gold, J. M., & McMahon, R. P. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050724 · Cited by 170
Self-citationSharing secrets: oxytocin and trust in schizophrenia
Kéri, S., Kiss, I., & Kelemen, O. (2009) · Social Neuroscience · doi:10.1080/17470910802319710 · Cited by 167
“Similarly to other previous studies (Gold et al., 1999; Hobart et al., 1999; Juhász et al., 2003; Loughland, Lewin, Carr, Sheedy, & Harris, 2007), Figure 1.”
ResultCognitive impairments in psychotic disorders: common mechanisms and measurement
Barch, D. M., & Sheffield, J. M. (2014) · World Psychiatry · doi:10.1002/wps.20145 · Cited by 154
The brief assessment of cognition in schizophrenia. Normative data for the Italian population
Anselmetti, S., Poletti, S., Ermoli, E., Bechi, M., Cappa, S., Venneri, A., Smeraldi, E., & Cavallaro, R. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0866-9 · Cited by 129
Depp, C. A., Moore, R. C., Dev, S. I., Mausbach, B. T., Eyler, L. T., & Granholm, E. L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.12.016 · Cited by 38
Patient satisfaction after acute admission for psychosis
Bø, B., Ottesen, Ø. H., Gjestad, R., Jørgensen, H. A., Kroken, R. A., Løberg, E.-M., & Johnsen, E. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1112831 · Cited by 29
Metadata
- Authors
- Gold, J. M., Queern, C., Iannone, V. N., & Buchanan, R. W.
- Venue
- American Journal of Psychiatry
- Published
- 1999-12-01
- Volume
- 156
- Issue
- 12
- Pages
- 1944-1950
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2118423385
- Cited by
- 325
- References
- 13
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.